These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6110251)

  • 1. [Determination in man of the beta blocking properties and the pharmacological half of pargolol (Author's transl)].
    Hugues FC; Julien D; Bors V; Mougeot G; Marche J
    Therapie; 1980; 35(4):475-81. PubMed ID: 6110251
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
    Bekes M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular effects of propanolol, alprenolol, oxprenolol and CS-359 during halothane anesthesia (author's transl)].
    Kubota M; Gotho Y; Furukawa K
    Masui; 1979 Aug; 28(8):797-804. PubMed ID: 43404
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological characterisation of -receptor blocking agents.
    Saameli K
    Jpn J Pharmacol; 1972; 22():Suppl22:13. PubMed ID: 4403917
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac effects of beta-adrenergic receptor antagonists.
    Ablad B; Carlsson B; Carlsson E; Dahlöf C; Ek L; Hultberg E
    Adv Cardiol; 1974; 12(0):290-302. PubMed ID: 4151859
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of beta-adrenergic blocking agents on the spontaneous motility of mice.
    Fabian HE; Izquierdo JA
    Arzneimittelforschung; 1972 Aug; 22(8):1375-6. PubMed ID: 4404659
    [No Abstract]   [Full Text] [Related]  

  • 8. Alprenolol and bromoacetylalprenololmenthane are competitive slowly reversible antagonists at the beta 1-adrenoceptors of rat left atria.
    Surman AJ; Doggrell SA
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):35-9. PubMed ID: 7678677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromoacetylalprenololmenthane: a potent irreversible antagonist of beta adrenergic elicited protein exocytosis in rat parotid cells.
    Kousvelari EE; Kusiak JW; Hand AR; Pitha J; Baum BJ
    J Pharmacol Exp Ther; 1983 Oct; 227(1):238-43. PubMed ID: 6194285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioenergetics in clinical medicine XV. Inhibition of coenzyme Q10-enzymes by clinically used adrenergic blockers of beta-receptors.
    Kishi T; Watanabe T; Folkers K
    Res Commun Chem Pathol Pharmacol; 1977 May; 17(1):157-64. PubMed ID: 17892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of hexobarbitone sodium-induced hynosis in mice by beta adrenergic receptor blocking agents.
    Singh KP
    Indian J Physiol Pharmacol; 1979; 23(1):52-4. PubMed ID: 35466
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of potencies of six beta-adrenoceptive blocking drugs in isolated rabbit atrium and guinea-pig trachea (author's transl)].
    Mao YK; Yang ZC
    Zhongguo Yao Li Xue Bao; 1980 Sep; 1(1):7-12. PubMed ID: 6121446
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
    Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):62-7. PubMed ID: 6129320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH).
    Békés M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Jun; 6(2):161-6. PubMed ID: 4404774
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for spare beta-adrenoceptors in the rabbit heart.
    Lee JR; Zhang X; Tenner TE
    Proc West Pharmacol Soc; 1999; 42():41-4. PubMed ID: 10697685
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clenbuterol: a new partial antagonist of the beta adrenergic receptors (author's transl)].
    Morales-Olivas FJ; Brugger AJ; Bedate H; García-Díez JM; Morcillo E; Esplugues J
    Arch Farmacol Toxicol; 1980 Aug; 6(2):131-8. PubMed ID: 6110409
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta-adrenergic inhibitors (pharmacologic data and deductions for therapeutic application)].
    Salvador M; Marco J; Couderc JJ; Cazard JC
    Cah Med; 1973 Oct; 14(10):877-82. PubMed ID: 4156916
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of four beta-blocking agents on some psychopharmacological tests in mice (author's transl)].
    Francès H; Puech AJ; Chermat R; Simon P
    Psychopharmacology (Berl); 1979 May; 63(1):43-8. PubMed ID: 38471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent effects of postnatal administration of beta-adrenergic ligands on the volume of sexually dimorphic nucleus of the preoptic area (SDN-POA) in rats.
    Izdebska-Straszak G; Gubala E; Jedrzejowska-Szypulka H; Klencki M; Wiczkowski A; Jarzab B
    Neuro Endocrinol Lett; 2006; 27(1-2):105-13. PubMed ID: 16648786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adrenergic beta-receptor blocking activity of (3-amino-2-hydroxy)propoxy-3, 4-dihydrocarbostyril derivatives in anesthetized dog (author's transl)].
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    Yakugaku Zasshi; 1974 May; 94(5):613-6. PubMed ID: 4153735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.